Curia Missouri Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is SODIUM OXYBATE, with a corresponding US DMF Number 27599.
Remarkably, this DMF maintains an Active status since its submission on September 26, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 28, 2014, and payment made on December 06, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II